

| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.2M | -2.4% |
| Cost of Revenue | $20.5M | -5.7% |
| R&D Expense | $14.4M | -10.9% |
| SG&A Expense | $9.8M | +5.3% |
| Operating Income | -$8.1M | +30.9% |
| Interest Expense | $37K | +0.0% |
| Pre-tax Income | -$8.1M | -93.9% |
| Income Tax | $184K | -20.7% |
| Net Income | -$8.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | -24.4% |
| Accounts Receivable | $8.4M | +4.7% |
| Current Assets | $30.9M | -17.7% |
| Total Assets | $56.8M | -13.7% |
| Current Liabilities | $12.1M | -4.8% |
| Total Liabilities | $12.7M | -11.5% |
| Stockholders' Equity | $44.1M | -14.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | +63.9% |
| Capital Expenditures | $2.9M | +112.1% |
| Investing Cash Flow | -$2.9M | -201.3% |
| Financing Cash Flow | -$1.5M | -375.6% |
| Free Cash Flow | -$5.2M | +33.0% |
| -87.8% |
| EPS (Basic) | -$0.19 | -90.0% |
| EPS (Diluted) | -$0.19 | -90.0% |